Dr. Thomas Ichim joins as full-time CSO

Founder of Batu Biologics Expands Involvement as Chief Scientific Officer

Thomas Ichim, PhD, will oversee the scientific development of the ValloVax therapeutic program

Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVax™, announced today the appointment of Thomas Ichim, PhD, to the position of Chief Scientific Officer.

Read the full article at businesswire.com

Continue →
0